help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0404
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sesti, G.
Right arrow Articles by Folli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sesti, G.
Right arrow Articles by Folli, F.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 9 5064-5069
Copyright © 2005 by The Endocrine Society

Impact of Common Polymorphisms in Candidate Genes for Insulin Resistance and Obesity on Weight Loss of Morbidly Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet

Giorgio Sesti, Lucia Perego, Marina Cardellini, Francesco Andreozzi, Cristina Ricasoli, Paola Vedani, Valeria Guzzi, Monica Marchi, Michele Paganelli, Gianfranco Ferla, Antonio E. Pontiroli, Marta Letizia Hribal and Franco Folli

Dipartimento di Medicina Sperimentale e Clinica (G.S., F.A., C.R., M.L.H.), Università Magna Græcia di Catanzaro, 88100 Catanzaro, Italy; Divisione di Medicina Interna (L.P., P.V., V.G., M.M., F.F.), Divisione di Chirurgia Generale (M.P., G.F.), Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, 20132 Milano, Italy; Department of Internal Medicine (M.C., M.L.H.), University of Rome-Tor Vergata, 00133 Rome, Italy; and Universitá di Milano, Cattedra di Medicina Interna and Seconda Divisione di Medicina Interna, Ospedale San Paolo (A.E.P.), 20142 Milano, Italy

Address all correspondence and requests for reprints to: Giorgio Sesti, M.D., Dipartimento Medicina Sperimentale e Clinica, Università Magna-Græcia di Catanzaro, Via Campanella, 115, 88100 Catanzaro, Italy. E-mail: sesti{at}unicz.it; or Franco Folli, M.D., Ph.D., Department of Internal Medicine, HS Raffaele, Via Olgettina 60, 20132 Milan, Italy. E-mail: folli.franco{at}hsr.it.

Context: It is unknown whether genetic factors that play an important role in body weight homeostasis influence the response to laparoscopic adjustable gastric banding (LAGB).

Objective: We investigated the impact of common polymorphisms in four candidate genes for insulin resistance on weight loss after LAGB.

Design: The design was a 6-month follow-up study.

Setting: The study setting was hospitalized care.

Patients: A total of 167 unrelated morbidly obese subjects were recruited according to the following criteria: age, 18–66 yr inclusive; and body mass index greater than 40 kg/m2 or greater than 35.0 kg/m2 in the presence of comorbidities.

Intervention: LAGB was used as an intervention.

Main Outcome Measure: Measure of correlation between weight loss and common polymorphisms in candidate genes for insulin resistance and obesity was the main outcome measure.

Results: The following single nucleotide polymorphisms were detected by digestion of PCR products with appropriate restriction enzymes: Gly972Arg of the insulin receptor substrate-1 gene, Pro12Ala of the proliferator-activated receptor-{gamma} gene, C-174G in the promoter of IL-6 gene, and G-866A in the promoter of uncoupling protein 2 gene. Baseline characteristics including body mass index did not differ between the genotypes. At the 6-month follow-up after LAGB, carriers of G-174G IL-6 genotype had lost more weight than G-174C or C-174C genotype (P = 0.037), and carriers of A-866A uncoupling protein 2 genotype had lost more weight as compared with G-866G (P = 0.018) and G-866A (P = 0.035) genotype, respectively. Weight loss was lower in carriers of Gly972Arg insulin receptor substrate-1 genotype than Gly972Gly carriers, but not statistically significant (P = 0.06). No difference between carriers of Pro12Ala and Pro12Pro proliferator-activated receptor-{gamma} genotype was observed.

Conclusions: These data demonstrate that genetic factors, which play an important role in the regulation of body weight, may account for differences in the therapeutic response to LAGB.




This article has been cited by other articles:


Home page
Arch SurgHome page
X. Chu, R. Erdman, M. Susek, H. Gerst, K. Derr, M. Al-Agha, G. C. Wood, C. Hartman, S. Yeager, M. A. Blosky, et al.
Association of Morbid Obesity With FTO and INSIG2 Allelic Variants
Arch Surg, March 1, 2008; 143(3): 235 - 240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society